Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Investing

Prohibition Kills

by July 10, 2024
July 10, 2024
Prohibition Kills

Jeffrey Miron

Over the past few years, multiple claimants have accused opioid manufacturers and related companies of misleading patients and doctors into believing their products are relatively safe; this allegedly caused expanded prescribing, addiction, and overdoses. Last month, the Supreme Court ruled against an $8 billion settlement that gave the owners of Purdue Pharma — the Sacklers — protection from future lawsuits. The court ruled that such protection is not authorized by bankruptcy law. 

These lawsuits, regardless of their legal merits, are unlikely to diminish the opioid overdose epidemic because they do not address the government policies that caused it and perpetuate it.

The risk of overdosing from the proper medical use of prescription opioids is low. As I wrote in a Cato policy analysis with Laura Nicolae and Greg Sollenberger: 

Opioid overdose deaths have risen dramatically in the United States over the past two decades. The standard explanation blames expanded prescribing and advertising of opioids beginning in the 1990s.

This “more prescribing, more deaths” explanation has spurred increased legal restrictions on opioid prescribing. Federal and state governments have enacted a variety of policies to curtail prescribing and doctor shopping, and the federal government has raided pain management facilities deemed to be overprescribing. Supporters believe these policies reduce the supply of prescription opioids and thereby decrease overdose deaths.

We find little support for this view. We instead suggest that the opioid epidemic has resulted from too many restrictions on prescribing, not too few. Rather than decreasing opioid overdose deaths, restrictions push users from prescription opioids toward diverted or illicit opioids, which increases the risk of overdose because consumers cannot easily assess drug potency or quality in underground markets. The implication of this “more restrictions, more deaths” explanation is that the United States should scale back restrictions on opioid prescribing, perhaps to the point of legalization.

The past five years have confirmed our conclusion from 2019. Prescribing has been declining, as has the number of overdoses attributed to prescription opioids. But overdoses from fentanyl, and total opioid overdoses, have risen sharply in recent years.

The lesson for policymakers is clear: prohibition kills. 

Lemoni Matsumoto, an undergraduate at the University of Chicago, contributed to this article.

0
FacebookTwitterGoogle +Pinterest
previous post
New York working hours increase by 2.4% but productivity drops by 1.8%
next post
Election Policy Roundup

You may also like

The New Deal and Recovery, Part 25: The...

March 20, 2023

US Citizens Don’t Have First Amendment Rights If...

April 15, 2025

Indoctrination, Choice, and the Constitution: Trump’s Education EOs

January 30, 2025

Prices and Price Controls: An Introduction

August 19, 2024

Climate Change and Hurricane Damage

September 26, 2024

Trump’s New Immigration Ban: An Arbitrary, Discriminatory Legal...

March 14, 2025

Big Government Doesn’t Want You to Think about...

June 24, 2024

States, Don’t Fear the Education Department Reaper

February 27, 2025

CBDC: Inclusion of the ‘Unbanked’ or Illusion?

August 30, 2023

Six Reforms to Enhance Transparency and Fiscal Accountability...

January 31, 2024

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • TSA tells Americans their Costco cards won’t fly at airport security despite love for hot dogs

      June 7, 2025
    • Trump announces China will restart rare earth mineral shipments to US after productive call

      June 7, 2025
    • Musk feud presents ‘unprecedented’ dynamic compared to past Trump disputes: expert

      June 7, 2025
    • Snub of Musk’s NASA nominee ally preceded sudden ‘big, beautiful bill’ criticism, Trump feud

      June 6, 2025
    • Supreme Court rules DOGE can access Social Security information

      June 6, 2025
    • US sanctions money laundering network aiding Iran as regime faces nuclear reprimand at IAEA

      June 6, 2025

    Categories

    • Business (8,149)
    • Investing (2,019)
    • Politics (15,558)
    • Stocks (3,134)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved